帕金森病及其他神经系统疾病中内源性尿单胺氧化酶抑制剂的排泄情况。

Endogenous urinary monoamine oxidase inhibitor excretion in Parkinson's disease and other neurological disorders.

作者信息

Ueki A, Willoughby J, Glover V, Sandler M, Stibbe K, Stern G M

机构信息

Bernhard Baron Memorial Research Laboratories, Queen Charlotte's Hospital, London, U.K.

出版信息

J Neural Transm Park Dis Dement Sect. 1989;1(4):263-8. doi: 10.1007/BF02263480.

DOI:10.1007/BF02263480

PMID:2597312

Abstract

In this study, urinary output of both neutral (tribulin) and basic monoamine oxidase inhibitory activity was measured in parkinsonian patients, other neurological patients and controls. No significant differences in output were found between these different groups. In general, tribulin output rose with age, in parallel with known changes in monoamine oxidase B activity.

摘要

在本研究中，对帕金森病患者、其他神经系统疾病患者及对照组测定了中性（刺蒺藜素）和碱性单胺氧化酶抑制活性的尿量。这些不同组之间未发现尿量有显著差异。一般来说，刺蒺藜素的尿量随年龄增加，与单胺氧化酶B活性的已知变化平行。